文献速递药物不良反应与药物警戒

统计数据信号与PRAC亚组风险讨论的一致性评估

Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk.
PubMed 文献 · Drug Saf · 2023-05-02

本研究基于FAERS 2004年至2021年第二季度数据,应用Sandberg亚组比例失衡方法及其变体筛查ADR高风险亚组,以PRAC 2015至2019年会议记录为参考标准评估一致性。纳入27个PRAC亚组示例对应1719个药物-事件组合,Sandberg方法仅检出2/27,方法变体检出14/27,总体一致性低;年龄和性别表现较好,妊娠和基础疾病因FAERS捕获不足需补充数据源。

要点

  • 亚组比例失衡评分与PRAC亚组风险讨论总体一致性低。
  • Sandberg方法仅检出27个示例中的2个,方法变体检出14个。
  • 年龄和性别亚组分析表现较好,妊娠和基础疾病需额外数据源。

核心结论

  • 亚组比例失衡评分与PRAC潜在亚组风险讨论之间一致性低。
  • 亚组分析对年龄和性别表现较好,对FAERS捕获不足的协变量如基础疾病和妊娠应补充其他数据源。

研究设计与样本

  • 应用Sandberg等描述的亚组比例失衡方法及其变体,对美国FAERS 2004年至2021年第二季度累计数据进行统计筛查。
  • 以2015至2019年PRAC会议记录中手动提取的亚组示例为参考集评估一致性,纳入与Sandberg方法重叠的亚组。
  • 共纳入27个PRAC亚组示例,代表FAERS中1719个亚组药物-事件组合。

主要发现

  • 使用Sandberg方法,27个示例中可检出2个(1个为年龄,1个为性别)。
  • 未检出妊娠和基础疾病的亚组示例。
  • 使用方法学变体,27个示例中可检出14个。

临床怎么用

  • 临床药学智能体在解读亚组比例失衡信号时需注意其与监管机构PRAC讨论的一致性有限。
  • 对年龄和性别亚组的统计筛查可优先参考,对妊娠和基础疾病应结合其他数据源评估。

局限性

  • 参考集仅来自2015至2019年PRAC会议记录,可能未覆盖全部亚组风险讨论。
  • FAERS对基础疾病和妊娠等协变量捕获不足,影响亚组分析检出能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Identifying individual characteristics or underlying conditions linked to adverse drug reactions (ADRs) can help optimise the benefit-risk ratio for individuals. A systematic evaluation of statistical methods to identify subgroups potentially at risk using spontaneous ADR report datasets is lacking. OBJECTIVES: In this study, we aimed to assess concordance between subgroup disproportionality scores and European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC) discussions of potential subgroup risk. METHODS: The subgroup disproportionality method described by Sandberg et al., and variants, were applied to statistically screen for subgroups at potential increased risk of ADRs, using data from the US FDA Adverse Event Reporting System (FAERS) cumulative from 2004 to quarter 2 2021. The reference set used to assess concordance was manually extracted from PRAC minutes from 2015 to 2019. Mentions of subgroups presenting potential differentiated risk and overlapping with the Sandberg method were included. RESULTS: Twenty-seven PRAC subgroup examples representing 1719 subgroup drug-event combinations (DECs) in FAERS were included. Using the Sandberg methodology, 2 of the 27 could be detected (one for age and one for sex). No subgroup examples for pregnancy and underlying condition were detected. With a methodological variant, 14 of 27 examples could be detected. CONCLUSIONS: We observed low concordance between subgroup disproportionality scores and PRAC discussions of potential subgroup risk. Subgroup analyses performed better for age and sex, while for covariates not well-captured in FAERS, such as underlying condition and pregnancy, additional data sources should be considered.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Mahaux O, Powell G, Haguinet F, et al. Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk. Drug Saf. 2023. PMID: 37131012. doi:10.1007/s40264-023-01306-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。